Form4insider filings, from the source

Insider holders · CIK 0001607678

Viking Therapeutics, Inc. · VKTX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
LIGAND PHARMACEUTICALS INC10% Owner6,038,083—6,038,083Sep 27, 2018 · 9:25 pm EDTForm 4
Brian LianPresident & CEO2,572,441—2,572,441Jul 29, 2026 · 8:07 pm EDTForm 4
Michael DinermanChief Operating Officer694,116—694,116May 6, 2015 · 8:19 pm EDTForm 4
Marianna ManciniChief Operating Officer422,760—422,760Jul 29, 2026 · 8:06 pm EDTForm 4
Greg ZanteChief Financial Officer212,204—212,204Jul 29, 2026 · 8:06 pm EDTForm 4
Rochelle HanleyChief Medical Officer160,836—160,836May 5, 2016 · 5:36 pm EDTForm 4
Hiroko MasamuneChief Development Officer141,063—141,063Jan 3, 2019 · 8:33 pm ESTForm 4
Michael MorneauVP, Finance and Administration91,991—91,991Jan 22, 2019 · 7:13 pm ESTForm 4
Lawson MacartneyDirector47,965—47,965May 31, 2018 · 6:57 pm EDTForm 4
Matthew W FoehrDirector39,250—39,250Nov 15, 2016 · 4:34 pm ESTForm 4
Charles A Rowland Jr.Director30,000—30,000May 31, 2018 · 7:02 pm EDTForm 4
J Matthew SingletonDirector9,500—9,500May 31, 2018 · 7:04 pm EDTForm 4
Stephen W WebsterDirector8,000—8,000May 31, 2018 · 6:59 pm EDTForm 4
Dorothy Elizabeth Kelly-GemmellDirector6,333—6,333Aug 7, 2026 · 4:34 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.